Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2526]

Researchers predict 1.4 million deaths from all cancers in 2019 in the EU

Researchers predict 1.4 million deaths from all cancers in 2019 in the EU

'Cancer-killing' blood cells can be activated to fight prostate cancer

'Cancer-killing' blood cells can be activated to fight prostate cancer

Early menopause in smokers linked to bladder cancer

Early menopause in smokers linked to bladder cancer

Individualised model could help guide treatment of non-metastatic prostate cancer

Individualised model could help guide treatment of non-metastatic prostate cancer

Adding docetaxel-based chemotherapy to standard treatment for high-risk prostate cancer

Adding docetaxel-based chemotherapy to standard treatment for high-risk prostate cancer

Web tool aims to better inform and refine need for treatment in early prostate cancer

Web tool aims to better inform and refine need for treatment in early prostate cancer

Last couple of months in Oncology with Dr. Bishal Gyawali: March 2019

Last couple of months in Oncology with Dr. Bishal Gyawali: March 2019

New ESMO guidelines include tivozanib recommendation for patients with advanced renal cell carcinoma

New ESMO guidelines include tivozanib recommendation for patients with advanced renal cell carcinoma

Old drugs bring new hope to a cancer that lacks precision therapy

Old drugs bring new hope to a cancer that lacks precision therapy

European approval for enzalutamide for adult men with high-risk non-metastatic castration-resistant prostate cancer

European approval for enzalutamide for adult men with high-risk non-metastatic castration-resistant prostate cancer

More from ecancer